Chronic Obstructive Pulmonary Disease: A Concise Review

被引：38

作者：

Balkissoon, Ron ^{[1
]}

Lommatzsch, Steve ^{[1
]}

Carolan, Brendan ^{[1
]}

机构：

[1] Natl Jewish Hlth, Div Pulm, Dept Med, Denver, CO 80206 USA

来源：

MEDICAL CLINICS OF NORTH AMERICA | 2011年 / 95卷 / 06期

基金：

美国国家卫生研究院;

关键词：

Chronic obstructive pulmonary disease; Guidelines; Chronic bronchitis; Emphysema; VOLUME-REDUCTION SURGERY; METERED-DOSE INHALER; VITAMIN-D DEFICIENCY; 50; MU-G; SALMETEROL/FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE; MACROLIDE ANTIBIOTICS; SMOKING-CESSATION; TRIPLE THERAPY; LONG-TERM;

D O I：

10.1016/j.mcna.2011.08.009

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Globally, chronic obstructive pulmonary disease (COPD) is a major cause of significant morbidity and mortality, and is now the third leading cause of death in the United States. Over the past 15 years there has been a surge of bench and translational research regarding the genetics and pathogenesis of COPD, and several large-scale clinical trials have introduced new treatment paradigms for COPD. Current research also demonstrates that COPD is not just a lung disease and that there are several potential extrapulmonary manifestations and comorbidities that should be evaluated and treated when one identifies an individual as having COPD.

引用

页码：1125 / +

页数：18

共 94 条

[1]

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial [J].

Aaron, Shawn D. ;

Vandemheen, Katherine L. ;

Fergusson, Dean ;

Maltais, Francois ;

Bourbeau, Jean ;

Goldstein, Roger ;

Balter, Meyer ;

O'Donnell, Denis ;

McIvor, Andrew ;

Sharma, Sat ;

Bishop, Graham ;

Anthony, John ;

Cowie, Robert ;

Field, Stephen ;

Hirsch, Andrew ;

Hernandez, Paul ;

Rivington, Robert ;

Road, Jeremy ;

Hoffstein, Victor ;

Hodder, Richard ;

Marciniuk, Darcy ;

McCormack, David ;

Fox, George ;

Cox, Gerard ;

Prins, Henry B. ;

Ford, Gordon ;

Bleskie, Dominique ;

Doucette, Steve ;

Mayers, Irvin ;

Chapman, Kenneth ;

Zamel, Noe ;

FitzGerald, Mark .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) :545-U15

[2]

Lymphocyte proliferative response to P6 of Haemophilus influenzae is associated with relative protection from exacerbations of chronic obstructive pulmonary disease [J].

Abe, Y ;

Murphy, TF ;

Sethi, S ;

Faden, HS ;

Dmochowski, J ;

Harabuchi, Y ;

Thanavala, YM .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) :967-971

[3]

Albert RK, 2011, AM J RESP CRIT CARE, V183

[4]

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: A systematic review of randomized placebo-controlled trials [J].

Alsaeedi, A ;

Sin, DD ;

McAlister, FA .

AMERICAN JOURNAL OF MEDICINE, 2002, 113 (01) :59-65

[5]

Immunomodulatory Effects of Macrolide Antibiotics - Part 1: Biological Mechanisms [J].

Altenburg, J. ;

de Graaff, C. S. ;

van der Werf, T. S. ;

Boersma, W. G. .

RESPIRATION, 2011, 81 (01) :67-74

[6]

Immunomodulatory Effects of Macrolide Antibiotics - Part 2: Advantages and Disadvantages of Long-Term, Low-Dose Macrolide Therapy [J].

Altenburg, J. ;

de Graaff, C. S. ;

van der Werf, T. S. ;

Boersma, W. G. .

RESPIRATION, 2011, 81 (01) :75-87

[7]

[Anonymous], 2009, MORB MORT 2009 CHART

[8]

[Anonymous], GLOB STRAT DIAGN MAN

[9]

LONG-TERM OXYGEN-THERAPY [J].

ANTHONISEN, NR .

ANNALS OF INTERNAL MEDICINE, 1983, 99 (04) :519-527

[10]

Systemic and mucosal antibody response to Moraxella catarrhalis after exacerbations of chronic obstructive pulmonary disease [J].

Bakri, F ;

Brauer, AL ;

Sethi, S ;

Murphy, TF .

JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (05) :632-640

← 1 2 3 4 5 6 7 8 9 10 →